B. Öberg

Trisodium Phosphonoformate, a New Antiviral Compound

Erik Helgstrand, B. Eriksson, N. G. Johansson et al. · Science · 1978 · 217 citations

Life Sciences, Medicinal Chemistry, Microbiology +14

Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors.

Klaus Überla, Christiane Stahl‐Hennig, D Böttiger et al. · Proceedings of the National Academy of Sciences · 1995 · 130 citations

Medicine, Infectious Diseases, Pharmacology +16

PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase

Lotta Vrang, B. Öberg · Antimicrobial Agents and Chemotherapy · 1986 · 83 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +15

Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors.

Jan Balzarini, Anna Karlsson, Anne‐Mieke Vandamme et al. · Proceedings of the National Academy of Sciences · 1993 · 79 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir

Anna‐Karin Larsson, K Stenberg, A.‐C. Ericson et al. · Antimicrobial Agents and Chemotherapy · 1986 · 78 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15